In a significant move to improve public health, the government of Burkina Faso has announced a major price reduction for essential generic medicines and various medical supplies. This initiative, supported by a state investment of 3 billion FCFA, is set to take effect on March 1, 2026, with the aim of making healthcare more accessible and equitable for all citizens.
The decision was finalized following a Council of Ministers meeting on February 12, 2026. The new pricing will apply to products distributed by the Centrale d’achat des médicaments essentiels génériques (CAMEG), the country’s central purchasing body for essential medicines.
According to the Minister of Health, Dr. Robert Lucien Jean-Claude Kargougou, the price cuts are substantial and vary by product type. Certain medical consumables will see their prices drop by as much as 72.73%. Significant reductions will also apply to pharmaceuticals, including a decrease of up to 67.27% for some tablet medications and up to 53.47% for injectable products. Syrups and suspensions will also become more affordable with a 20% price reduction.
This reform is designed to alleviate the financial strain of healthcare expenses on households, enhance access to vital treatments, and foster greater fairness in the provision of medical care throughout the nation. The state’s 3 billion FCFA financial backing is crucial to implementing these changes successfully.
This latest measure follows a similar price reduction in May 2025, which had a budgetary impact of approximately 5 billion FCFA. It reaffirms the authorities’ dedication to ensuring that quality healthcare is within reach for every citizen in Burkina Faso.
